Caszyme

Description

Caszyme provides customized CRISPR solutions using a flexible platform and expertise in nucleases, mRNA, protein engineering, and evolution to develop therapeutics, agri‑tech, diagnostics, and research tools for customers.

Caszyme is located in the Lithuania ecosystem.

Related

• CutanosCutanos develops LC-TDS, a ligand-based delivery platform that uses langerin-specific glycomimetic ligands on lipid nanoparticles to…
• VRG TherapeuticsVRG Therapeutics designs therapeutic miniproteins using a proprietary platform that combines AI-driven protein engineering with wet-lab…
• EurogentecEurogentec provides life-science products and CDMO manufacturing for research, diagnostics and therapeutics, producing oligonucleotides,…
• bit.biobit.bio provides deterministically programmed human iPSC-derived cells and CRISPR screening services for research and drug discovery,…
• Camtech InnovationsCamtech Innovations develops and manufactures diagnostic assays, microfluidic chips and laboratory services for point-of-care diagnostics,…
• SNIPR BIOMESNIPR BIOME develops CRISPR-based medicines that use bacteriophages, engineered probiotics, and CRISPR systems to target…
• ResQ BiotechResQ Biotech builds a living-cell discovery platform that biosynthesizes and functionally screens ultra-large libraries to identify…
• NucleraNuclera builds and supplies eProtein Discovery systems, cartridges, reagents and services for multiplex cell-free protein screening used by…
• IBA LifesciencesIBA Lifesciences develops research tools based on Strep-tag® technology for protein and cell isolation, providing purification and analysis…